Evaluating the Impact of Interventions by a Multidisciplinary Pediatric Behavioral Health Medication Initiative Workgroup on Medication Prescribing Trends in a Medicaid Population

Monday, March 27, 2017
Poster about pediatric behavioral health program in Medicaid
Ashley N. Camilo, PharmD, MBA
University of Massachusetts Medical School
Neha Kashalikar, PharmD
University of Massachusetts Medical School
Thomas Pomfret, PharmD, MPH, BCPS
Donna Faber, PharmD, BCPS
Kimberly Lenz, PharmD
University of Massachusetts Medical School
Joel Goldstein, MD
Massachusetts Department of Mental Health
Karen Clements, ScD
University of Massachusetts Medical School
Michael C. Angelini, MA, PharmD, BCPP
University of Massachusetts Medical School
Patricia Leto, PharmD
University of Massachusetts Medical School
Paul L. Jeffrey, PharmD
University of Massachusetts Medical School

In 2011, the U.S. Government Accountability Office (GAO) reported foster and non-foster children in the MassHealth, Massachusetts Medicaid program, exhibited the highest rate of behavioral health medication (BHM) utilization, with 49.3% of all Medicaid children being prescribed a psychotropic medication, and 39.1% of children in foster care prescribed these medications.

The MassHealth Pharmacy Program, which is managed by UMass Medical School, implemented a PBHMI Workgroup in November 2014 with the collaboration of the Department of Children and Families and the Department of Mental Health.

The workgroup proactively requires prior authorization (PA) for specific medications or combinations of BHMs prescribed to members less than 18 years of age. Interventions include telephonic prescriber outreach by a child/adolescent psychiatrist to discuss opportunities for regimen simplification, drug interactions or toxicity, and to encourage evidence-based practices.

An analysis of the workgroup suggests a peer-to-peer outreach program is associated with increased awareness and implementation of evidence based medicine in a pediatric population treated with behavioral health medications.

Conference 
Academy of Managed Care & Specialty Pharmacy Annual Conference 2017